Rare Cancers – more common than you think
ESMO Video Commentary:
Personalised medicine in head and neck cancers
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers 2016
Milan, Italy - 25 Nov - 27 Nov 2016 - Find out more here
15 Sep 2016
Anticancer chemotherapy in teenagers and young adults: managing long term side effects
Information for generalists on late effects of anticancer chemotherapy that may affect quality of life.
06 Sep 2016
Improving Outcomes for Children With Rare Cancers
Rare tumour registry created to improve the outcomes of children with rare tumours
18 Aug 2016
CAR T-cells Targeting the CD4 Protein Granted FDA Orphan Drug Designation
The indication concerns the treatment of peripheral T-cell lymphoma